Cara Therapeutics Inc. (NASDAQ:CARA) previous close was $14.18 while the outstanding shares total 49.92M. The firm has a beta of 1.10, a 12-month trailing P/E
Cara Therapeutics Inc. (NASDAQ:CARA) shares fell to a low of $12.975 before closing at $13.24. Intraday shares traded counted 0.74 million, which was 41.4% higher
Cara Therapeutics Inc. (NASDAQ:CARA) has a beta of 1.13, a 12-month trailing P/E ratio of 73.84. The stock’s Relative Strength Index (RSI) is 32.93, with
Cara Therapeutics Inc. (NASDAQ:CARA) has a beta of 1.13, a 12-month trailing P/E ratio of 73.84. The stock’s Relative Strength Index (RSI) is 32.93, with
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
© 2024, Fueled by Smart TechOne
